Literature DB >> 25287071

The first steps towards the era of personalised vaccinology: predicting adverse reactions.

P Pellegrino1, F S Falvella1, V Perrone1, C Carnovale1, T Brusadelli1, M Pozzi2, S Antoniazzi3, S Cheli1, C Perrotta1, E Clementi4, S Radice1.   

Abstract

Until now, the occurrence of adverse reactions among individuals inoculated with identical vaccines has been ascribed to unpredictable stochastic processes. Recent advances in pharmacogenomics indicate that some features of host response to immunisation are influenced by genetic traits, henceforth predictable. The ability to predict the adverse reaction to vaccination would represent an important step towards the development of personalised vaccinology and could enhance public confidence in the safety of vaccines. Herein, we have reviewed all the available information on the association between genetic variants and the risk for healthy subjects to develop adverse reactions.

Mesh:

Substances:

Year:  2014        PMID: 25287071     DOI: 10.1038/tpj.2014.57

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  47 in total

1.  A taxonomy of reasoning flaws in the anti-vaccine movement.

Authors:  Robert M Jacobson; Paul V Targonski; Gregory A Poland
Journal:  Vaccine       Date:  2007-01-18       Impact factor: 3.641

Review 2.  Can HPV immunisation cause ADEM? Two case reports and literature review.

Authors:  Paolo Pellegrino; Carla Carnovale; Valentina Perrone; Stefania Antoniazzi; Marco Pozzi; Emilio Clementi; Sonia Radice
Journal:  Mult Scler       Date:  2013-08-22       Impact factor: 6.312

3.  On the possible interaction between vaccines and drugs.

Authors:  Paolo Pellegrino; Carla Carnovale; Valentina Perrone; Dionigi Salvati; Marta Gentili; Tatiana Brusadelli; Marco Pozzi; Stefania Antoniazzi; Emilio Clementi; Sonia Radice
Journal:  Eur J Clin Pharmacol       Date:  2013-12-05       Impact factor: 2.953

4.  Epidemiological analysis on two decades of hospitalisations for meningitis in the United States.

Authors:  P Pellegrino; C Carnovale; V Perrone; D Salvati; M Gentili; T Brusadelli; S Antoniazzi; M Pozzi; S Radice; E Clementi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-23       Impact factor: 3.267

5.  Smallpox vaccination does not elevate systemic levels of prothrombotic proteins associated with ischemic cardiac events.

Authors:  Julia F Shaklee; Thomas R Talbot; James A S Muldowney; Douglas E Vaughan; Javed Butler; Frances House; James E Crowe; L Harris Smith; Kathryn M Edwards
Journal:  J Infect Dis       Date:  2005-01-25       Impact factor: 5.226

6.  HLA-DR class II associations with rubella vaccine-induced joint manifestations.

Authors:  L A Mitchell; A J Tingle; L MacWilliam; C Horne; P Keown; L K Gaur; G T Nepom
Journal:  J Infect Dis       Date:  1998-01       Impact factor: 5.226

7.  Cytokine expression patterns associated with systemic adverse events following smallpox immunization.

Authors:  Brett A McKinney; David M Reif; Michael T Rock; Kathryn M Edwards; Stephen F Kingsmore; Jason H Moore; James E Crowe
Journal:  J Infect Dis       Date:  2006-07-13       Impact factor: 5.226

8.  The immunogenetics of smallpox vaccination.

Authors:  Samuel L Stanley; Sharon E Frey; Patricia Taillon-Miller; Jianhua Guo; Raymond D Miller; Daniel C Koboldt; Michael Elashoff; Ryan Christensen; Nancy L Saccone; Robert B Belshe
Journal:  J Infect Dis       Date:  2007-06-04       Impact factor: 5.226

9.  Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial.

Authors:  S L Charland; B C Agatep; V Herrera; B Schrader; F W Frueh; M Ryvkin; J Shabbeer; J J Devlin; H R Superko; E J Stanek
Journal:  Pharmacogenomics J       Date:  2013-08-27       Impact factor: 3.550

10.  Acute disseminated encephalomyelitis onset: evaluation based on vaccine adverse events reporting systems.

Authors:  Paolo Pellegrino; Carla Carnovale; Valentina Perrone; Marco Pozzi; Stefania Antoniazzi; Emilio Clementi; Sonia Radice
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

View more
  9 in total

Review 1.  Vaccine-Drug Interactions: Cytokines, Cytochromes, and Molecular Mechanisms.

Authors:  Paolo Pellegrino; Cristiana Perrotta; Emilio Clementi; Sonia Radice
Journal:  Drug Saf       Date:  2015-09       Impact factor: 5.606

2.  The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems.

Authors:  Paolo Pellegrino; Valentina Perrone; Marco Pozzi; Carla Carnovale; Cristiana Perrotta; Emilio Clementi; Sonia Radice
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 3.  The role of Toll-like receptor 4 polymorphisms in vaccine immune response.

Authors:  P Pellegrino; F S Falvella; S Cheli; C Perrotta; E Clementi; S Radice
Journal:  Pharmacogenomics J       Date:  2015-03-31       Impact factor: 3.550

Review 4.  Recent Advances in Application of Pharmacogenomics for Biotherapeutics.

Authors:  Pramod B Mahajan
Journal:  AAPS J       Date:  2016-03-23       Impact factor: 4.009

Review 5.  Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions.

Authors:  Ramón Cacabelos; Vinogran Naidoo; Lola Corzo; Natalia Cacabelos; Juan C Carril
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

Review 6.  N. meningitidis and TLR Polymorphisms: A Fascinating Immunomodulatory Network.

Authors:  Elena Gianchecchi; Alessandro Torelli; Giulia Piccini; Simona Piccirella; Emanuele Montomoli
Journal:  Vaccines (Basel)       Date:  2016-05-27

Review 7.  Severe somatoform and dysautonomic syndromes after HPV vaccination: case series and review of literature.

Authors:  Beniamino Palmieri; Dimitri Poddighe; Maria Vadalà; Carmen Laurino; Carla Carnovale; Emilio Clementi
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

8.  Comment on "Safety of Human Papillomavirus Vaccines: An Updated Review".

Authors:  Rebecca Ellen Chandler; I Ralph Edwards; Marie Lindquist
Journal:  Drug Saf       Date:  2018-05       Impact factor: 5.606

9.  Prediction of post-vaccination Guillain-Barré syndrome using data from a passive surveillance system.

Authors:  Chongliang Luo; Ying Jiang; Jingcheng Du; Jiayi Tong; Jing Huang; Vincent Lo Re; Susan S Ellenberg; Gregory A Poland; Cui Tao; Yong Chen
Journal:  Pharmacoepidemiol Drug Saf       Date:  2021-02-23       Impact factor: 2.732

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.